MODERN ELECTROSURGICAL TECHNOLOGY IN THE SURGICAL TREATMENT OF TOXIC GOITER
Purpose: to evaluate the effectiveness of the Valleylab FT-10 electrocoagulator with TissueFect™ technology in the surgical treatment of diffuse toxic goiter. A clinical observation of a patient with diffuse toxic goiter is presented. Medical history covers 6 years: repeated thyrotoxic crises, signs of compression of the neck organs. The patient systematically received treatment from an endocrinologist. The volume of the thyroid gland is 275 cm3. Indication for surgery: ineffectiveness of the conservative therapy, compression syndrome. Treatment: surgery - thyroidectomy under general anesthesia. Kocher incision of 8 cm on the anterior surface of the neck. The operation was performed according to the standard technique. During the operation, a Valleylab FT10 electrocoagulator with TissueFect™ technology was used. Simultaneous dissection and coagulation of the tissues of the thyroid gland were performed. Vessel ligation was not required. Due to the absence of bleeding, the visualization of the parathyroid glands and laryngeal nerves improved, which made it possible to avoid damage to these structures. The duration of the operation was 35 minutes. The postoperative period was without complications. The patient was discharged on the 4th day after the operation. Histological conclusion: colloid goiter. Prognosis: the patient is predicted to have postoperative hypothyroidism. In the further postoperative period, she will receive hormone replacement therapy from an endocrinologist for life. Conclusion. This clinical case demonstrates the significant clinical effect of using the modern Valleylab FT-10 electrocoagulator with TissueFect™ technology. Its use does not require ligation of vessels, improves the visualization of the parathyroid glands and nerves, avoids complications and reduces the duration of the operation.